AzTrials
AzTrials

Social Isolation or LonelinessNCT07782905

Talk2gether Program for Social Connection in Older Adults

A study testing Talk2gether program in people with Social Isolation or Loneliness, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to see if it is feasible to recruit and retain older adults in a, weekly phone call program delivered through the Harris County Precinct 2 Healthcare and Social Services Team and to see how participation in the program affect older adults' loneliness, social isolation, psychological… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Social Isolation or Loneliness
What is being tested?
Talk2gether program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
3 Aug 2026to 3 Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • able to provide informed consent
  • able to speaks English or Spanish
  • able to hear sufficiently using the telephone

Who cannot join

  • Need for another person to consent on the participant's behalf
  • suspected or confirmed decision-making capacity impairments
  • uncontrolled psychiatric illnesses such as schizophrenia, paranoia, delusion, or delirium

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • The University of Texas Health Science Center at Houston

    Houston, Texas, 77030

    Jason Burnett, PhD, 713-873-4685, Jason.Burnett@uth.tmc.edu

    Jordan Broussard, (713) 500-0321, Jordan.Broussard@uth.tmc.edu

Other trials in United States

About this study

Official title: Talk2gether Program

The purpose of this study is to see if it is feasible to recruit and retain older adults in a, weekly phone call program delivered through the Harris County Precinct 2 Healthcare and Social Services Team and to see how participation in the program affect older adults' loneliness, social isolation, psychological well-being, and satisfaction, and what barriers or challenges arise during implementation

Being tested
Talk2gether program
Keywords
Loneliness, social connectedness, psychological well-being
Medical subject headings
Social Isolation, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Talk2gether programBehavioural

    Participants will be paired with a trained team member. The team member will then initiate contact with the older adult(s) to begin 90 days of weekly social calls. These weekly social calls will be mostly unstructured, but supported by resource and conversation guides. At the end of 90 days, if the older adult wishes to continue to receive calls, that request will be accommodated

Study groups in NCT07782905
Study groupRoleWhat they receive
Talk2gether programExperimentalNot described
Receives: Behavioral: Talk2gether program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Program Feasibility as assessed by number of participants recruited

    Measured: end of intervention (90 days after baseline)

  2. Program Feasibility as assessed by number of participants that adhered to the weekly calls

    Measured: end of intervention (90 days after baseline)

  3. Feasibility as assessed by number of participants that completed the program

    Measured: end of intervention (90 days after baseline)

  4. Feasibility as assessed by number of participants that encountered barriers or challenges as assessed by the Client Satisfaction Questionnaire (CSQ-8)

    This is an 8 item questionnaire and Items 2, 4, 5, and 8 are reverse scored. Total scores range from 8 to 32, with the higher number indicating greater satisfaction

    Measured: end of intervention (90 days after baseline)

  5. Feasibility as assessed by number of participants that encountered barriers or challenges as reported on the Caller and Older Adult feedback form

    Measured: end of intervention (90 days after baseline)

Secondary outcomes (6)
  1. Change in social connectedness as assessed by the Lubben Social Network Scale-6

    This is a 6-item self-report measure assessing perceived social support and social network size from family and friends. Each item is scored from 0 to 5, and total scores range from 0 to 30. Higher scores indicate greater social connectedness and lower risk of social isolation

    Measured: baseline, post-intervention (Day 90)

  2. Change in loneliness as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation scale

    This is an 8 item scale. Each item is rated on a 5-point scale from 1(never) to 5 ( always). Raw scores range from 8 to 40 and are converted to PROMIS T-scores, with a mean of 50 and standard deviation of 10 in the reference population. Higher scores indicate greater perceived social isolation/loneliness.

    Measured: Baseline, end of intervention (90 days)

  3. Change in depressive symptoms as assessed by the Patient Health Questionnaire-2

    This is a 2-item self-report measure . Each item is scored from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 6, with higher scores indicating greater depressive symptom burden.

    Measured: Baseline, end of intervention (90 days)

  4. Change in signs of elder mistreatment as assessed by the Elder Mistreatment Screening and Response Tool (EM-SART).

    This is a 3 item questionnaire and each will be scored as either 1(yes) or 0(no) for a maximum score of 3. Higher scores or more endorsed concerns indicate a greater number of signs suggestive of elder mistreatment

    Measured: Baseline, end of intervention (90 days)

  5. Change in sense of purpose using the 7-item Ryff Purpose in Life Scale.

    This is a 7 item questionnaire and each item is rated on a Likert-type scale, commonly from 1(strongly disagree) to 6( strongly agree). Negatively worded items are reverse scored, and item scores are summed to generate a total score. Total scores range from 7 to 42, with higher scores indicating a greater sense of purpose in life.

    Measured: Baseline, end of intervention (90 days)

  6. Client satisfaction as assessed by the Client Satisfaction Questionnaire

    This is an 8 item questionnaire. Scores are summed across items once. Items 2, 4, 5, and 8 are reverse scored. Total scores range from 8 to 32, with the higher number indicating greater satisfaction

    Measured: end of intervention (90 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Aug 2026
  2. Study start3 Aug 2026 (estimated)
  3. Primary completion3 Aug 2028 (estimated)
  4. Study completion3 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07782905
Sponsor's protocol ID
HSC-MS-26-0434
Status last verified
Aug 2026
First submitted
19 Aug 2026
Last updated
24 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Talk2gether program in people with Social Isolation or Loneliness, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jason Burnett, PhD ((713) 873-4685, Jason.Burnett@uth.tmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Program Feasibility as assessed by number of participants recruited (time frame: end of intervention (90 days after baseline)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in